Cargando…

Comparison of Various Ultrasound-Based Malignant Risk Stratification Systems on an Occasion for Assessing Thyroid Nodules in Hashimoto’s Thyroiditis

PURPOSE: To compare the diagnostic performance and unnecessary ultrasound-guided fine-needle aspiration (US-FNA) biopsy rate of the 2015 American Thyroid Association (ATA), 2016 Korean Society of Thyroid Radiology (KSThR), and 2017 American College of Radiology (ACR) guidelines for patients with and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Tianxue, Xu, Shaokun, Zhang, Xianfeng, Xu, Chenke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946008/
https://www.ncbi.nlm.nih.gov/pubmed/36845342
http://dx.doi.org/10.2147/IJGM.S398601
_version_ 1784892246943858688
author Zhao, Tianxue
Xu, Shaokun
Zhang, Xianfeng
Xu, Chenke
author_facet Zhao, Tianxue
Xu, Shaokun
Zhang, Xianfeng
Xu, Chenke
author_sort Zhao, Tianxue
collection PubMed
description PURPOSE: To compare the diagnostic performance and unnecessary ultrasound-guided fine-needle aspiration (US-FNA) biopsy rate of the 2015 American Thyroid Association (ATA), 2016 Korean Society of Thyroid Radiology (KSThR), and 2017 American College of Radiology (ACR) guidelines for patients with and without Hashimoto’s thyroiditis (HT). PATIENTS AND METHODS: This retrospective study included 716 nodules from 696 consecutive patients, which were classified using the categories defined by the three guidelines: ATA, KSThR, and ACR. The malignancy risk in each category was calculated and the diagnostic performance and unnecessary fine-needle aspiration (FNA) rates of the three guidelines were compared. RESULTS: In total, 426 malignant and 290 benign nodules were identified. Patients with malignant nodules had lower total thyroxine levels and higher thyroid-stimulating hormone, thyroid peroxidase antibody, and thyroglobulin antibody levels than those without malignant nodules (all P<0.01). The margin difference was significant in non-HT patients (P<0.01), but comparable in HT patients (P=0.55). The calculated malignancy risks of high and intermediate suspicion nodules in the ATA and KSThR guidelines and moderately suspicious nodules in the ACR guidelines were significantly lower in non-HT patients compared with HT patients (P<0.05). The ACR guidelines showed the lowest sensitivity, highest specificity, and lowest unnecessary FNA rates in patients with and without HT. Compared to non-HT patients, HT patients had significantly lower unnecessary FNA rates (P<0.01). CONCLUSION: HT was associated with a higher malignancy rate of thyroid nodules with intermediate suspicion according to the ATA, KSThR, and ACR guidelines. The three guidelines, especially ACR, were likely to be more effective and could allow a greater reduction in the percentage of benign nodules biopsied in patients with HT.
format Online
Article
Text
id pubmed-9946008
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-99460082023-02-23 Comparison of Various Ultrasound-Based Malignant Risk Stratification Systems on an Occasion for Assessing Thyroid Nodules in Hashimoto’s Thyroiditis Zhao, Tianxue Xu, Shaokun Zhang, Xianfeng Xu, Chenke Int J Gen Med Original Research PURPOSE: To compare the diagnostic performance and unnecessary ultrasound-guided fine-needle aspiration (US-FNA) biopsy rate of the 2015 American Thyroid Association (ATA), 2016 Korean Society of Thyroid Radiology (KSThR), and 2017 American College of Radiology (ACR) guidelines for patients with and without Hashimoto’s thyroiditis (HT). PATIENTS AND METHODS: This retrospective study included 716 nodules from 696 consecutive patients, which were classified using the categories defined by the three guidelines: ATA, KSThR, and ACR. The malignancy risk in each category was calculated and the diagnostic performance and unnecessary fine-needle aspiration (FNA) rates of the three guidelines were compared. RESULTS: In total, 426 malignant and 290 benign nodules were identified. Patients with malignant nodules had lower total thyroxine levels and higher thyroid-stimulating hormone, thyroid peroxidase antibody, and thyroglobulin antibody levels than those without malignant nodules (all P<0.01). The margin difference was significant in non-HT patients (P<0.01), but comparable in HT patients (P=0.55). The calculated malignancy risks of high and intermediate suspicion nodules in the ATA and KSThR guidelines and moderately suspicious nodules in the ACR guidelines were significantly lower in non-HT patients compared with HT patients (P<0.05). The ACR guidelines showed the lowest sensitivity, highest specificity, and lowest unnecessary FNA rates in patients with and without HT. Compared to non-HT patients, HT patients had significantly lower unnecessary FNA rates (P<0.01). CONCLUSION: HT was associated with a higher malignancy rate of thyroid nodules with intermediate suspicion according to the ATA, KSThR, and ACR guidelines. The three guidelines, especially ACR, were likely to be more effective and could allow a greater reduction in the percentage of benign nodules biopsied in patients with HT. Dove 2023-02-18 /pmc/articles/PMC9946008/ /pubmed/36845342 http://dx.doi.org/10.2147/IJGM.S398601 Text en © 2023 Zhao et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhao, Tianxue
Xu, Shaokun
Zhang, Xianfeng
Xu, Chenke
Comparison of Various Ultrasound-Based Malignant Risk Stratification Systems on an Occasion for Assessing Thyroid Nodules in Hashimoto’s Thyroiditis
title Comparison of Various Ultrasound-Based Malignant Risk Stratification Systems on an Occasion for Assessing Thyroid Nodules in Hashimoto’s Thyroiditis
title_full Comparison of Various Ultrasound-Based Malignant Risk Stratification Systems on an Occasion for Assessing Thyroid Nodules in Hashimoto’s Thyroiditis
title_fullStr Comparison of Various Ultrasound-Based Malignant Risk Stratification Systems on an Occasion for Assessing Thyroid Nodules in Hashimoto’s Thyroiditis
title_full_unstemmed Comparison of Various Ultrasound-Based Malignant Risk Stratification Systems on an Occasion for Assessing Thyroid Nodules in Hashimoto’s Thyroiditis
title_short Comparison of Various Ultrasound-Based Malignant Risk Stratification Systems on an Occasion for Assessing Thyroid Nodules in Hashimoto’s Thyroiditis
title_sort comparison of various ultrasound-based malignant risk stratification systems on an occasion for assessing thyroid nodules in hashimoto’s thyroiditis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946008/
https://www.ncbi.nlm.nih.gov/pubmed/36845342
http://dx.doi.org/10.2147/IJGM.S398601
work_keys_str_mv AT zhaotianxue comparisonofvariousultrasoundbasedmalignantriskstratificationsystemsonanoccasionforassessingthyroidnodulesinhashimotosthyroiditis
AT xushaokun comparisonofvariousultrasoundbasedmalignantriskstratificationsystemsonanoccasionforassessingthyroidnodulesinhashimotosthyroiditis
AT zhangxianfeng comparisonofvariousultrasoundbasedmalignantriskstratificationsystemsonanoccasionforassessingthyroidnodulesinhashimotosthyroiditis
AT xuchenke comparisonofvariousultrasoundbasedmalignantriskstratificationsystemsonanoccasionforassessingthyroidnodulesinhashimotosthyroiditis